Clinical Trials: An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis

Article

This clinical trial will determine if AL-46383A ophthalmic solution is an effective treatment for adenoviral conjunctivitis.

Study Type: Interventional

Age/Gender Requirements: 6 years+ (male/female)

Sponsor: Alcon Research

Purpose: To determine the safety and efficacy of AL-46383A Ophthalmic Solution in the treatment of adenoviral conjunctivitis.

Click here to access this third-party resource.

Related Videos
Video 2 - "Differentiating Medication Non-Adherence From Underlying Comorbidities"
Video 1 - "Defining Resistant Diabetes"
Stephanie Nahas, MD, MSEd | Credit: Jefferson Health
Kelley Branch, MD, MS | Credit: University of Washington Medicine
Alayne Markland, DO | Credit: VA.gov
© 2024 MJH Life Sciences

All rights reserved.